Spécialités pharmaceutiques à base de Bosutinib, de Nilotinib et de Axitinib
Awarded
The competition has ended and a winner has been selected.
- Deadline
- 8. aprilExpired
- Award
- Price only
Brief
Healthcare Public Procurement (HeCaPP) heeft een overeenkomst gesloten met EG en ACCORD HEALTHCARE voor de levering van farmaceutische producten op basis van Bosutinib, Nilotinib en Axitinib in België. De overeenkomst heeft een looptijd van 4 jaar en een totale waarde van 266.521 euro. Er is één bod ontvangen.
Farmasøytisk engroshandel
Result
- ACCORD HEALTHCAREWinner
- Eurogenerics nvWinner
- 1Number of bids
- €266,521Contract value
Custom Assessment Criteria
Get answers to your bid/no-bid criteria
Set them up once and Cobrief answers them in every tender
Will you bid?
The agent sets up the bid and writes the first draft. Free for 14 days.
Award Criteria
Description
Prix
Source
No source found in the documents. Check the weight against the tender documents.
Previous winners
Who are you up against?
The suppliers who have won similar contracts at Healthcare Public Procurement (HeCaPP)
From the notice
Spécialités pharmaceutiques à base de Bosutinib, de Nilotinib et de Axitinib
Contact
Anna MANGIALETTOanna.mangialetto@hecapp.be- ResultType
- Arr. de Bruxelles-Capitale/Arr. Brussel-HoofdstadLocation
- 33600000Main codePharmaceutical products